Koninklijke Philips N.V. (NYSE:PHG - Get Free Report) saw a large drop in short interest during the month of August. As of August 31st, there was short interest totaling 2,470,000 shares, a drop of 32.3% from the August 15th total of 3,650,000 shares. Based on an average daily volume of 982,800 shares, the days-to-cover ratio is currently 2.5 days. Approximately 0.3% of the shares of the company are sold short. Approximately 0.3% of the shares of the company are sold short. Based on an average daily volume of 982,800 shares, the days-to-cover ratio is currently 2.5 days.
Institutional Trading of Koninklijke Philips
A number of institutional investors have recently modified their holdings of PHG. AlphaCore Capital LLC purchased a new stake in shares of Koninklijke Philips in the second quarter valued at approximately $41,000. Bessemer Group Inc. raised its holdings in Koninklijke Philips by 2,935.4% during the first quarter. Bessemer Group Inc. now owns 1,973 shares of the technology company's stock worth $51,000 after purchasing an additional 1,908 shares during the last quarter. Whipplewood Advisors LLC raised its holdings in Koninklijke Philips by 39.1% during the second quarter. Whipplewood Advisors LLC now owns 2,108 shares of the technology company's stock worth $51,000 after purchasing an additional 592 shares during the last quarter. MAI Capital Management raised its holdings in Koninklijke Philips by 167.7% during the second quarter. MAI Capital Management now owns 2,380 shares of the technology company's stock worth $57,000 after purchasing an additional 1,491 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd raised its holdings in Koninklijke Philips by 1,170.3% during the first quarter. Caitong International Asset Management Co. Ltd now owns 2,439 shares of the technology company's stock worth $62,000 after purchasing an additional 2,247 shares during the last quarter. 13.67% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Separately, Wall Street Zen downgraded Koninklijke Philips from a "buy" rating to a "hold" rating in a research note on Saturday, August 2nd. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Buy".
Read Our Latest Stock Report on PHG
Koninklijke Philips Stock Down 0.2%
Koninklijke Philips stock opened at $28.15 on Tuesday. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.26 and a quick ratio of 0.81. Koninklijke Philips has a 1-year low of $21.48 and a 1-year high of $32.91. The company has a market cap of $27.11 billion, a PE ratio of 148.16, a price-to-earnings-growth ratio of 0.76 and a beta of 0.81. The stock's 50 day moving average price is $26.62 and its 200 day moving average price is $25.09.
Koninklijke Philips (NYSE:PHG - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The technology company reported $0.41 earnings per share for the quarter, beating analysts' consensus estimates of $0.29 by $0.12. Koninklijke Philips had a return on equity of 11.95% and a net margin of 1.00%.The firm had revenue of $5.05 billion for the quarter, compared to the consensus estimate of $4.35 billion. On average, sell-side analysts predict that Koninklijke Philips will post 1.63 EPS for the current fiscal year.
About Koninklijke Philips
(
Get Free Report)
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Koninklijke Philips, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Koninklijke Philips wasn't on the list.
While Koninklijke Philips currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.